OncoCyte Corp (NASDAQ:OCX)

2.26
Delayed Data
As of Nov 30
 -0.06 / -2.59%
Today’s Change
1.81
Today|||52-Week Range
6.57
-5.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization283.0K387.0K580.0K559.0K
 
 
 
 
 
 
Operating ExpensesGross Income-283.0K-387.0K-580.0K-559.0K
 
 
 
 
 
General Expenses8.4M10.8M18.3M14.0M
 
 
 
 
 
Research And Development4.5M5.7M7.2M5.8M
 
 
 
 
 
Total Operating Expenses8.7M11.1M18.8M14.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.7M-11.1M-18.8M-14.6M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.1M
 
 
Interest Expense On Debt19.0K28.0K217.0K216.0K
 
 
 
 
 
Other Expenses2.0K0.00-309.0K91.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.7M-11.2M-19.4M-15.8M
 
 
 
 
 
Net Income-8.7M-11.2M-19.4M-15.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.0M26.5M30.2M37.9M
 
 
 
 
 
Shares To Calculate EPS Diluted21.0M26.5M30.2M37.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.42-$0.64-$0.42
 
 
 
 
 
EPS Diluted-$0.42-$0.42-$0.64-$0.42